BC
PFE icon

Barnett & Company’s Pfizer PFE Stock Holding History

Barnett & Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.84M Sell
136,857
-29,507
-18% -$786K 2.99% 10
2025
Q4 		$4.14M Sell
166,364
-39,523
-19% -$997K 3.34% 6
2025
Q3 		$5.25M Sell
205,887
-2,722
-1% -$67.2K 4.06% 6
2025
Q2 		$5.06M Buy
208,609
+4,144
+2% +$96.6K 3.98% 5
2025
Q1 		$5.18M Sell
204,465
-18,433
-8% -$482K 4.33% 5
2024
Q4 		$5.91M Buy
222,898
+9,273
+4% +$252K 3.87% 7
2024
Q3 		$6.18M Buy
213,625
+11,970
+6% +$349K 4.08% 7
2024
Q2 		$5.64M Buy
201,655
+8,230
+4% +$227K 4.05% 8
2024
Q1 		$5.37M Buy
193,425
+70,191
+57% +$1.95M 3.67% 8
2023
Q4 		$3.55M Sell
123,234
-7,582
-6% -$229K 2.66% 10
2023
Q3 		$4.34M Buy
130,816
+13,284
+11% +$470K 3.39% 9
2023
Q2 		$4.31M Buy
117,532
+14,900
+15% +$580K 3.2% 9
2023
Q1 		$4.19M Buy
102,632
+6,530
+7% +$282K 3.18% 10
2022
Q4 		$4.92M Buy
96,102
+595
+0.6% +$28.5K 3.76% 6
2022
Q3 		$4.18M Buy
95,507
+1,902
+2% +$92.4K 3.69% 7
2022
Q2 		$4.91M Buy
93,605
+951
+1% +$48.5K 3.92% 5
2022
Q1 		$4.8M Buy
92,654
+327
+0.4% +$17K 3.4% 7
2021
Q4 		$5.45M Sell
92,327
-123
-0.1% -$6.09K 3.8% 2
2021
Q3 		$3.98M Sell
92,450
-3,736
-4% -$166K 2.99% 11
2021
Q2 		$3.77M Buy
96,186
+18,402
+24% +$716K 2.49% 11
2021
Q1 		$2.82M Buy
77,784
+25,926
+50% +$921K 1.5% 22
2020
Q4 		$1.91M Sell
51,858
-5,289
-9% -$194K 1.2% 25
2020
Q3 		$1.99M Buy
57,147
+5,675
+11% +$199K 1.42% 21
2020
Q2 		$1.6M Buy
51,472
+49,643
+2,714% +$1.69M 1.3% 20
2020
Q1 		$57K Sell
1,829
-84
-4% -$2.86K 0.05% 129
2019
Q4 		$71K Buy
1,913
+767
+67% +$27.3K 0.04% 143
2019
Q3 		$39K Buy
1,146
+85
+8% +$3.09K 0.02% 183
2019
Q2 		$44K Sell
1,061
-166
-14% -$6.59K 0.02% 176
2019
Q1 		$49K Hold
1,227
– – 0.03% 174
2018
Q4 		$51K Hold
1,227
– – 0.03% 171
2018
Q3 		$51K Buy
1,227
+381
+45% +$14.7K 0.02% 183
2018
Q2 		$29K Buy
846
+91
+12% +$3.11K 0.01% 208
2018
Q1 		$25K Sell
755
-843
-53% -$29K 0.01% 220
2017
Q4 		$55K Sell
1,598
-474
-23% -$16.2K 0.03% 182
2017
Q3 		$70K Hold
2,072
– – 0.04% 166
2017
Q2 		$66K Buy
2,072
+738
+55% +$23.3K 0.03% 188
2017
Q1 		$43K Sell
1,334
-1,022
-43% -$32.2K 0.02% 192
2016
Q4 		$73K Hold
2,356
– – 0.04% 189
2016
Q3 		$76K Buy
2,356
+2,286
+3,266% +$76.4K 0.04% 189
2016
Q2 		$2K Hold
70
– – ﹤0.01% 372
2016
Q1 		$2K Buy
+70
New +$2K ﹤0.01% 389

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Barnett & Company's PFE Position: Q1 2026 in Review

Barnett & Company reduced its Pfizer (PFE) stake by 18% in Q1 2026, selling an estimated $786K and leaving 136,857 shares worth $3.84M. The position accounts for 2.99% of the portfolio, ranked #10.

Barnett & Company first reported a position in PFE in Q1 2016 and has held it in 41 quarters since. The position peaked at $6.18M in Q3 2024. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Barnett & Company held 136,857 shares of Pfizer worth $3.84M as of Q1 2026.
  • Barnett & Company sold 29,507 Pfizer shares in Q1 2026, an estimated $786K.
  • Pfizer made up 2.99% of Barnett & Company's portfolio in Q1 2026, its #10 holding.
  • Barnett & Company first reported a position in Pfizer in Q1 2016 and has held it in 41 quarters since.
  • Barnett & Company's Pfizer position peaked at $6.18M in Q3 2024.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Barnett & Company's 13F filing for Q1 2026, filed 30 Apr 2026.